Search

The effects of nonmetallic elements Sulfur (S), Phosphorus (P) and Carbon (C) on the decolorisation of azo dye direct blue 6 (DB6) by using ball-milled (BM) Co-free AlCrFeMn (S0) high-entropy alloy (HEA) are presented for the first time in this work. We report the approach of adding S, P and C into S0 HEA in a single step by ball milling, and it is environment friendly method. Moreover, HEAs added with S, P and C do not cause secondary pollution of water during decolorisation recation. DB6 dye solution (200 mg/L) can be fully decolorised in 0.3, 1.9 and 3.3 min with 0.5 g/L of BM AlCrFeMnS (SS), AlCrFeMnP (SP), and AlCrFeMnC (SC), which are about 42, 6.6 and 3.8 times faster than that of S0, respectively. The efficiency of SS for DB6 is 126,000 times that of commercially available pure iron powders. The activation energy of SS is 36.3 kJ/mol, which is lower than that of S0 (54.6 kJ/mol). The extremely high decolorisation efficiency is closely related with the formation of a large number of galvanic cells in SS, SP and SC between the metal and nonmetal elements, which greatly increases the amount and efficiency of electron transfer. The decolorisation efficiency of DB6 solution is assessed by ultraviolet–visible absorption spectrophotometry. The decolorisation rate follows pseudo-first-order reaction kinetics with respect to dye concentration. The results of this study provide some enlightenment for researchers in the application of HEAs in wastewater treatment.

The feasibility and performance of using calcined coal gangue (CCG) to substitute metakaolin (MK) as the precursor to prepare alkali-activated materials (AAMs) were thoroughly evaluated by conducting combined experiments of flowability test, mechanical measurement, calorimetry and microstructure analysis, etc. It was found that the increased substitution ratio of CCG to MK can increase the flowability of the prepared paste by up to 28.1% and decrease its viscosity by up to 55.8%. In addition, a prolonged setting time of up to 31.8% was found with the increased substitution amount of CCG to MK, which can be attributed to the low reactivity of CCG compared to that of MK. Lastly, even though the presence of CCG can lead to a decrease in the early compressive strength of the hardened paste, a highly recovered long-term mechanical property can be found due to the continuous reaction of CCG. All of these results prove the feasibility of using CCG as one co-blended precursor with MK to prepare alkali-activated materials.

On 20 July 2021, an extreme rainstorm battered Zhengzhou in China’s Henan Province, killing 302 people, including 14 individuals who drowned in a subway tunnel and 6 who drowned in a road tunnel. As the global climate warms, extreme weather events similar to the Zhengzhou flood will become more frequent, with increasingly catastrophic consequences for society. Taking a case study-based approach by focusing on the record-breaking Zhengzhou flood, this paper examines the governance capacity of inland cities in North China for managing extreme precipitation and flooding events from the perspective of the flood risk management process. Based on in-depth case analysis, our paper hypothesizes that inland cities in North China still have low risk perceptions of extreme weather events, which was manifested in insufficient pre-disaster preparation and prevention, poor risk communication, and slow emergency response. Accordingly, it is recommended that inland cities update their risk perceptions of extreme rainfall and flooding events, which are no longer low-probability, high-impact “black swans”, but turning into high-probability, high-impact “gray rhinos.” In particular, cities must make sufficient preparation for extreme weather events by revising contingency plans and strengthening their implementation, improving risk communication of meteorological warnings, and synchronizing emergency response with meteorological warnings.

Abstract Background The relationship between fibrosis-4 (FIB-4) index and clinical outcomes in patients with acute kidney injury (AKI) is unclear. We aimed to investigate the association between FIB-4 index and all-cause mortality in critically ill patients with AKI. Methods We used data from the Multiparameter Intelligent Monitoring in Intensive Care III (MIMIC-III) database (v1.4). The FIB-4 score was calculated using the existing formulas. logistic regression model, and Cox proportional hazards model were used to assessed the relationship between the FIB-4 index and in-hospital,28-day and 90-day mortality, respectively. Results A total of 3592 patients with AKI included in the data analysis. 395 (10.99%) patients died during hospitalization and 458 (12.74%) patients died in 28-day. During the 90-day follow-up, 893 (22.54%) patients were dead. An elevated FIB-4 value was significantly associated with increased in-hospital mortality when used as a continuous variable (odds ratio [OR] 1.183, 95% confidence interval [CI] 1.072–1.305, P = 0.002) and as a quartile variable (OR of Q2 to Q4 1.216–1.744, with Q1 as reference). FIB-4 was positively associated with 28-day mortality of AKI patients with hazard ratio (HR) of 1.097 (95% CI 1.008, 1.194) and 1.098 (95% 1.032, 1.167) for 90-day mortality, respectively. Conclusion This study demonstrated the FIB-4 index is associated with clinical outcomes in critically ill patients with acute kidney injury.

Background: Presently, colistin is commercially available in two different forms, namely, colistin sulfate and its sulphomethylated derivative, colistimethate sodium (CMS). However, in the currently reported studies, most of the clinical studies on colistin for parenteral use are referred to as CMS. Data on the pharmacokinetics (PK), clinical efficacy, and side effects of colistin sulfate in clinical use have not been reported.Methods: This retrospective study was performed on carbapenem-resistant organism (CRO)-infected patients treated with colistin sulfate for more than 72 h. The population pharmacokinetic model was developed using the NONMEM program. The clinical outcomes including clinical treatment efficacy, microbiological eradication, and nephrotoxicity were assessed. Monte Carlo simulation was utilized to calculate the probability of target attainment (PTA) in patients with normal or decreased renal function.Results: A total of 42 patients were enrolled, of which 25 (59.52%) patients were considered clinical treatment success and 29 (69.06%) patients had successful bacteria elimination at the end of treatment. Remarkably, no patient developed colistin sulfate-related nephrotoxicity. A total of 112 colistin concentrations with a range of 0.28–6.20 mg/L were included for PK modeling. The PK characteristic of colistin was well illustrated by a one-compartment model with linear elimination, and creatinine clearance (CrCL) was identified as a covariate on the clearance of colistin sulfate that significantly explained inter-individual variability. Monte Carlo simulations showed that the recommended dose regimen of colistin sulfate, according to the label sheet, of a daily dose of 1–1.5 million IU/day, given in 2–3 doses, could attain PTA > 90% for MICs ≤ 0.5 μg/mL, and that a daily dose of 1 million IU/day could pose a risk of subtherapeutic exposure for MIC ≥1 μg/ml in renal healthy patients.Conclusion: Renal function significantly affects the clearance of colistin sulfate. A dose of 750,000 U every 12 h was recommended for pathogens with MIC ≤1 μg/ml. The dosage recommended by the label inserts had a risk of subtherapeutic exposure for pathogens with MIC ≥2 μg/ml. Despite higher exposure to colistin in patients with acute renal insufficiency, dose reduction was not recommended.